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  1 
INTRODUCTION 
Bacteria are able to communicate and behave like a multicellular organism 
forming biofilms, highly organized structures consisting of cells embedded 
within a matrix of extracellular polymeric substance (EPS) and attached to a 
surface. As a matter of fact, bacteria exist in nature in a planktonic single-cell 
state or in a sessile multicellular state, the biofilm (Bhinu, 2005); biofilms are 
abundant in many industrial, environmental and clinical settings, such as, for 
example, food processing environments, potable water and medical devices 
(Bryers, 2008; Kokare, et al., 2009). In particular, bacterial biofilms found on the 
surface of medical devices are a major cause of hospital-associated infections 
(Lindsay and von Holy, 2006; Wenzel, 2007). Moreover, biofilms formed by 
pathogens play an important role in the infection of living tissues and are 
responsible for the resistance to antibiotics and to the host immune system 
(Bryers, 2008; Moreau-Marquis, et al., 2008). Bacteria growing as a microbial 
community are less sensitive to treatments with antimicrobial agents compared 
to planktonic cells (Bhinu, 2005; Moreau-Marquis, et al., 2008) and produce 
many virulence factors (Wagner, et al., 2004). According to the Centers for 
Disease Control and Prevention, 65% of all infections in developed countries 
are caused by biofilms. 
 
Pseudomonas aeruginosa 
A good model organism to study biofilm is the opportunistic human pathogen 
Pseudomonas aeruginosa, leading cause of both community- and hospital-
acquired infections (13% of all nosocomial infections) (Moreau-Marquis, et al., 
2008). P. aeruginosa is the major cause of death in patients of cystic fibrosis 
(CF), a genetic disease affecting 1/2500 newborns in Europe (Driscoll, et al., 
2007). In the CF lung the environment is poor of oxygen and rich of nitrate; 
under these conditions, P.aeruginosa is able to survive thanks to its anaerobic 
metabolism (Barraud, et al., 2006; Hassett, et al., 2002; Moreau-Marquis, et al., 
2008) causing chronic infections (Hassett, et al., 2002).  The stagnant mucus 
overlaying the CF lung epithelium constitutes a nitrate-rich 
microaerobic/anaerobic environment (fig. 1.1); nitrate in CF mucus is generated 
in part by the host inflammatory response to infection via NO. In this 
environment, P. aeruginosa produces energy from nitrate also using the 
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metabolic pathway of denitrification (Alvarez-Ortega and Harwood, 2007; 
Hassett, et al., 2002) (fig. 1.1). Four reductases are involved in this process 
(Zumft, 1997), namely, nitrate reductase (Nar), NiR, Nor, and nitrous oxide 
reductase (N2OR), whose expression is tightly regulated, being the 
intermediate NO a cytotoxic compound. Genetic mutants lacking nar and nir 
genes show swarming defects and reduced virulence (Van Alst, et al., 2007). 
The molecular mechanisms controlling enhanced biofilm formation during 
anaerobic growth are not clearly defined.  
 
 
Figure 1.1 Denitrification, pathogenesis, and biofilm formation in Pseudomonas aeruginosa. 
 
Low concentrations of NO have been shown to promote biofilm dispersion 
(Barraud, et al., 2006); on the other hand, Yoon and coworkers (Yoon, et al., 
2011) have shown that P. aeruginosa PAO1 grown anaerobically is more 
elongated than that grown aerobically and is defective in cell division. Elongated 
cells easily form highly cohesive clumps, thus yielding a robust biofilm. Cell 
elongation is dependent on the presence of NiR and is repressed in P. 
aeruginosa PAO1 in the presence of an NO antagonist (2-(4-carboxyphenyl)-
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide [carboxy-PTIO]); these evidence 
suggests a link between cell elongation, NO, and anaerobic respiration (Yoon, 
et al., 2011). Importantly, the nonelongated NiR-deficient mutant failed to form 
biofilm, while the wildtype PAO1 is highly elongated and formed robust 
biofilm. In addition to its role in anaerobic growth of P. aeruginosa, the NiR 
activity controls other important aspects of pathogenesis even under 
conditions where O2 is apparently not limiting, including motility, initiation of 
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biofilm formation, and virulence. As an example, a recent study has 
demonstrated that the NO produced by P. aeruginosa NiR regulates the 
activity of type III secretion system (Van Alst, et al., 2009), an apparatus 
whereby cytotoxic effector proteins are directly secreted into the host cell 
cytoplasm after contact of the bacterium with a target cell. Therefore, in P. 
aeruginosa, pathogenesis, biofilm formation, and denitrification, expecially nitrite 
reduction, are closely related. The enzyme responsible for nitrite reduction to 
NO is P. aeruginosa cytochrome cd1 nitrite reductase (PA-cd1NiR), a 
homodimer containing one c-heme and one d1-heme group in each subunit.  
The d1-heme (3,8-dioxo-17-acrylate-porphyrindione) is a partially saturated 
macrocycle which is synthesized by a specialized pathway present only in 
denitrifiers (strongly induced in P. aeruginosa upon nitrite treatment). The d1-
heme cofactor confers peculiar and physiologically relevant feature of all 
cd1NiRs, such as the rapid dissociation of NO (Rinaldo, et al., 2011), and the 
high affinity for nitrite (and other anions such as cyanide) (Jafferji, et al., 2000; 
Sun, et al., 2002). These behaviours are remarkably different from that 
observed in the b-type heme-containing proteins.  
Therefore, the ability of P. aeruginosa to survive in the low O2 environment of 
the airway mucus of CF patients by using anaerobic metabolism and forming 
robust biofilms represent an important medical problem. P. aeruginosa is 
intrinsically resistant to a wide array of antibiotics; moreover, it is prone to 
acquire new resistance genes through horizontal gene transfer and it produces 
an impressive array of virulence factors. The low efficacy of existing therapies in 
eradicating P. aeruginosa infection calls for the development of new therapeutic 
options (Castiglione, et al., 2011).  
Within the frame of a previous project in our lab, during the very first part of 
my PhD a detailed analysis of the reactivity of NIR with NO has been carried 
out in order to improve the comprehension of the catalytic mechanism of 
these enzyme. In such context my main contribution during my PhD course 
has been to start a novel research line whose primary aim was to improve the 
knowledge on the molecular mechanism of c-di-GMP-dependent biofilm 
formation in P. aeruginosa. 
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Communication in biofilm formation: the nucleotides signalling  
The biofilm formation is a multistage process that occurs step by step and 
which comprises formation of conditioning layer, bacterial adhesion, bacterial 
growth and the dispersion of some cells that often go to colonize other 
surfaces (biofilm expantion) (Kokare, et al., 2009)  
Biofilm formation takes place via two major signalling systems, the quorum 
sensing (QS) system and nucleotides signalling system. The QS system is a 
form of population-dependent bacterial cell-to-cell communication based on 
secretion and detection of small molecules induced by environmental stimuli. 
On the other hand, the cyclic nucleotide second messengers control an array 
of cellular processes linking environmental sensing with intracellular responses, 
representing a cornerstone signal transduction mechanism in all domains of life. 
Both prokaryotes and eukaryotes utilize linear and cyclic nucleotides to 
regulate diverse cellular processes in response to extracellular cues. In bacteria, 
a plethora of cyclic nucleotides as well as some linear nucleotides have 
emerged as important second messengers involved in the regulation of 
processes that regulate virulence factor production or biofilm formation. 
Quorum sensing regulates these same processes (Sintim, et al., 2010), and 
accumulating evidence now points to an interaction between signalling by 
nucleotides and QS, the small molecules that bacteria use to make ‘‘decisions’’ 
(Rutherford and Bassler, 2012; Sifri, 2008). 
Over the last few years, the universe of bacterial cyclic nucleotide messengers 
has been rapidly expanding (fig. 1.2).  In 1957, Earl Sutherland, who would later 
receive the Nobel Prize in 1971, discovered that cAMP mediated the 
hyperglycaemic effects of epinephrine and glucagon (Berthet, et al., 1957). 
A few years later, in 1963, cGMP was isolated from rat urine (Ashman, et al., 
1963) and it took a decade before it was demonstrated in 1974 that cGMP 
was not unique to eukaryotes but also existed in prokaryotes. (Bernlohr, et al., 
1974). In 1970, Cashel and co-workers first reported the existence of ppGpp 
and pppGpp in E. coli (Cashel and Kalbacher, 1970) and it was later shown that 
the concentrations of ppGpp and pppGpp increased during stress. (Magnusson, 
et al., 2005). It would take another decade before the next nucleotide second 
messenger would be discovered in bacteria.  
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Figure 1.2. Structure of nucleotide second messengers found in bacteria. 
 
In 1987 Benziman discovered that c-di-GMP (fig. 1.2) acted as an allosteric 
modulator of cellulose synthase in Gluconacetobacter xylinus (formerly called 
Acetobacter xylinum) (Ross, et al., 1987), but only 15 years later the c-di-GMP 
rose from obscurity to the limelight of a ubiquitous second messenger 
(Ryjenkov, et al., 2005). c-di-GMP is now known to control the transition from 
a single-cell motile state to a surface-attached multicellular state (Jenal, 2004) as 
well as virulence factor production in a number of clinically important bacteria 
and hence there is immense interest in c-di-GMP signalling. In the multicellular 
state, c-di-GMP plays a central role in formation and dissolution of biofilms by 
regulating – via diverse mechanisms – production of extracellular 
polysaccharides, adhesive proteins, pili and flagella (Wolfe and Visick, 2009). 
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Almost two decades after Benziman’s seminal discovery of cyclic dinucleotide 
signalling in bacteria, Hopfner reported that bacteria also use c-di-AMP for 
signalling (fig. 1.2) (Witte, et al., 2008).  
c-di-GMP signa ll ing - C-di-GMP is an ubiquitous intracellular second 
messenger crucial in physiology and pathogenesis of a variety of bacteria, 
including those of clinical relevance. In fact, this signal molecule controls 
complex prokaryotic processes such as virulence, motility and biofilm formation 
(fig. 1.3A) (Romling, et al., 2005; Schirmer and Jenal, 2009) hence there is 
immense interest in c-di-GMP signalling (Jenal, 2004).  
 
Figure 1.3. A) Cyclic-di-GMP controls many cellular processes like motility, virulence, biofilm 
formation and differentiation. B) Cyclic-di-GMP turnover: Cyclic-di-GMP synthesis and 
degradation are, respectively, controlled by two classes of enzymes, diguanylate cyclases 
(DGC), characterized by a GGDEF domain, and phosphodiesterases (PDE), characterized by 
an EAL or a HD-GYP domain.  
 
During biofilm formation, the pattern of gene expression is changed with 
respect to planktonic cells and new intracellular signalling pathways are 
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activated. When c-di-GMP reaches a threshold concentration in response to 
environmental signals, it induces a response regulating gene expression that 
stimulates the switching between the motile planktonic and the sessile lifestyle 
(Jenal, 2004), as well as the formation of extracellular polymeric substance. 
Therefore, biofilm formation can be viewed as a developmental process 
(Kokare, et al., 2009), regulated by the key signal molecule c-di-GMP.  
 
C-di-GMP biosynthesis, degradation and signalling 
The intracellular levels of c-di-GMP are modulated by the opposite activity of 
diguanilate cyclase (DGC), and phosphodiesterase (PDE) enzymes (fig. 1.3B). 
DGC enzymes synthesize c-di-GMP starting from two GTP molecules, while 
PDEs hydrolysed it producing linear 5’phosohoguanylyl-(3’-5’)-guanosine 
(pGpG) or GMP. DGCs are often called GGDEF proteins due to the 
conserved aminoacids found in their active site; similarly, PDEs are grouped 
into the EAL and the HD-GYP families (Camilli and Bassler, 2006; Cotter and 
Stibitz, 2007; Hengge, 2009). GGDEF and EAL domains are also found in 
tandem within the same protein; these hybrid proteins frequently show only 
one enzymatic activity with the catalytically inactive domain, potentially serving 
a regulatory function (Jenal and Malone, 2006) Structural and functional studies 
of LapD, an internal membrane protein that regulates surface attachment in 
Pseudomonas fluorescens, and of FimX from P.aeruginosa (Navarro, et al., 2009) 
indicate that both hybrid proteins function as c-di-GMP-sensors, able to 
communicate the levels of c-di-GMP from the cytoplasm to the periplasm 
(Newell, et al., 2009); nucleotide binding studies in solution confirmed that EAL 
domain works as the sole c-di-GMP binding module of FimX (Navarro, et al., 
2009). 
Most DGCs and PDEs are also associated with known or hypothetical signal 
input domains (globin-like, CheY-like, PAS/PACM, GAF, HAMP, CHASE4 or 
membrane sensory domains MHYT or MASE1) (Galperin, et al., 2001), 
putatively involved in sensing a range of environmental signals (oxygen, blue 
light, nutrient starvation, antibiotics, etc). Little is known on the intracellular 
receptors of c-di-GMP, which convert the increase/decrease of c-di-GMP into 
a biological response. Possible c-di-GMP-sensing domains include the PilZ, 
BcsA or PelD domains (Camilli and Bassler, 2006; Lee, et al., 2007; Ryjenkov, et 
al., 2006), the GGDEF/EAL containing hybrid proteins (Newell, et al., 2009) 
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and even riboswitches (Sudarsan, et al., 2008). However, the high number of 
genes coding for GGDEF, EAL, HD-GYP or GGDEF-EAL fused proteins in the 
genome of many bacterial species (Hengge, 2009) indicate that bacteria 
regulate the c-di-GMP turnover and biofilm formation in an extremely 
sophisticated manner. The large number of GGDEF and EAL domain proteins 
in a single species is somewhat puzzling (Hengge, 2009). In general, Gram-
positive bacteria have less of DGC/PDE proteins than Gram-negative bacteria; 
by contrast, proteins containing the HD-GYP domain are less common or 
even absent in some species such as E.coli, whereas in other species, such as 
Thermotoga maritima, they account for all PDE activity in the cell (Galperin, 
2005; Galperin, et al., 2001). The number of these proteins encoded in 
bacterial genomes is highly variable (for example over 60 in Vibrio cholerae, 41 
in P. aeruginosa, none in Helicobacter pylori): this may reflect the ability to 
survive in different environmental niches. However, how the DGCs and PDEs 
function together to produce a coherent output signal is still unclear; different 
c-di-GMP circuits could be separate in time and in space, through 
compartmentalization (Jenal and Malone, 2006; Malone, et al., 2012; Massie, et 
al., 2012). 
Given the heterogeneity and the large number of factors involved, the c-di-
GMP signalling pathway appears to be very elaborate and difficult to 
understand. To date, few biochemical data on the proteins involved in c-di-
GMP turnover are available. A brief summary of the major structural and 
functional data on the DGCs and the PDEs is given below. 
 
Diguanylate cyclases 
The structure of the GGDEF domain resembles that of the adenylate cyclase 
catalytic domain, as evident in the structure of the PleD response regulator 
from Caulobacter crescentus (Chan, et al., 2004; Christen, et al., 2006), that is 
considered as a prototype DGC. PleD has REC1-REC2-GGDEF domains; the 
two CheY-like phosphoryl receiver (REC) domains modulate the activity of the 
protein. Activation is achieved by phosphorylation of an aspartate residue that 
induces dimerization: two GTP molecules, bound to the active sites of the 
GGDEF domains, come together to form c-di-GMP. PleD is regulated by non-
competitive product inhibition: c-di-GMP can bind to a high affinity inhibition 
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site (I-site) causing a conformational change that separates the two GGDEF 
domains, thus hampering catalysis (Paul, et al., 2007).  
In P. aeruginosa, the only known DGC structure is that of WspR (De, et al., 
2009) (fig. 1.4). This DGC has a similar domain organization as PleD, but lacks 
the second CheY-like domain. As observed with PleD, WspR appears to be 
regulated by phosphorylation of the N-terminal CheY-like domain (Hickman, et 
al., 2005). 
 
Figure 1.4. Crystal structure of WspR from P. aeruginosa: The N-terminal CheY-like phospho-
receiver domain is connected via a helical stalk to the GGDEF domain with diguanylate cyclase 
activity. Cyclic-di-GMP molecules bound to the inhibitory site (I-site) are located distal to the 
active site and are shown as black sticks. Mg2+ ions are shown as black spheres (Tesmer, et al., 
1997) (Protein Data Bank id. 3BRE). 
 
In the structure of the protein (fig. 1.4) this domain contains the Mg2+ ion 
(necessary for catalysis) and it is connected via a helical stalk to the GGDEF 
domain; the latter is oriented such that the two active sites face each other, 
similarly to the active conformation of adenylate cyclases (Tesmer, et al., 1997). 
In addition, binding of a c-di-GMP dimer to the conserved inhibitory site (I-site) 
is observed (Christen, et al., 2006) (fig. 1.4). In summary, the protein is 
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activated by phosphorylation and inhibited by product binding to the I-site; 
however, the feedback inhibition mechanism of WspR is even more complex 
than in PleD (De, et al., 2008).  
Surprisingly, recent data indicate that the c-di-GMP has also a role in signalling 
of eukaryotic cells (Chen and Schaap, 2012). In fact, species representing all 
major groups of Dictyostelia contain one or more conserved diguanylate 
cyclase that were previously only found in eubacteria.  
D. discoideum is a eukaryote that transitions from a collection of unicellular 
amoebae into a multicellular slug and then into a fruiting body within its 
lifetime. Chen Z. and Schaap P. demonstrated that the Dictyostelium discoideum 
diguanylate cyclase (DgcA) synthesizes c-di-GMP and is essential for the 
transition from slug migration to fructification (Chen and Schaap, 2012). 
Thus in Dictyostelia as in bacteria, c-di-GMP also triggers the transition from 
motile slugs into sessile fruiting bodies, and the question arises of whether this 
represents either convergent evolution or deep ancestral connections between 
Dictyostelid fructification and bacterial sessility. 
Furthermore, numerous studies have demonstrated that cyclic dinucleotides 
are potent immunostimulatory compounds (Chen, et al., 2010; Karaolis, et al., 
2007); recently, it was identified as mammalian innate immune sensor of c-di-
GMP the a transmembrane protein called STING (STimulator of INterferon 
Genes) (Burdette, et al., 2011), that is known for its role as signalling adaptor 
linking cytosolic detection of pathogen-derived DNA to the IFN induction 
(Ishikawa and Barber, 2008; Ishikawa, et al., 2009; Jin, et al., 2008; Sun, et al., 
2009; Zhong, et al., 2008). Recognition of microbial ligands leads to the 
production of cytokines, such as type I interferons (IFN) that are essential for 
successful pathogen elimination.  
Burdette D.L. and co-workers demonstrated that STING can bind directly c-di-
GMP and that the cyclic dinucleotide sensing and DNA sensing can be 
uncoupled, suggesting that these two pathways are discrete but share STING 
as a common signalling molecule (Burdette, et al., 2011). Thus, the finding that 
STING is a direct detector of cyclic dinucleotides provides insight into the 
fundamental mechanisms by which the innate immune system can detect 
bacterial infection and allow to valuate the cyclic dinucleotides as novel vaccine 
adjuvants and immunotherapeutics (Chen, et al., 2010; Karaolis, et al., 2007). 
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EAL and HD-GYP Phosphodiesterases  
Both classes of PDE require Mg2+ or Mn2+ ions for the phosphodiester 
hydrolysis. (Christen, et al., 2005). To date, a detailed mechanism for the 
cleavage of c-di-GMP by PDEs has not been worked out but analyses of crystal 
structures of PDEs, with or without bound c-di-GMP, have provided some 
clues about c-di-GMP hydrolysis. 
The crystal structures of few proteins with EAL domains have been 
determined: TdEAL from Thiobacillus denitrificans, YkuI from Bacillus subtilis 
(Minasov, et al., 2009), BlrP1 from Klebsiella pneumonite (Barends, et al., 2009). 
The general fold of the EAL domain consists of a beta-barrel harbouring the 
catalytic residues at the top of the barrel.  
In the case of P. aeruginosa, the catalytic mechanism of the RocR protein has 
been discussed and its structural model has been settled (Rao, et al., 2008); 
Despite extensive screening of crystallization conditions, the wild-type RocR 
could not be crystallized. Very recently, the crystal structure of a mutant 
protein (R286W) was been obtained (Chen, et al., 2012) revealing that RocR 
adopts a highly unusual quaternary structure in solution with its four subunits 
adopting two distinct conformations (fig. 1.5).  
 
Figure 1.5. Schematic depiction of the RocR tetramer highlighting the open conformation of its 
C and D subunits, which form a saddle-like structure into which the REC domains of the 
closed subunits A and B are inserted, forming the core of the tetramer. The EAL active sites 
are represented as three black triangles. EAL active sites of subunits C and D are concealed 
(crossed circle) in trans by the REC domains located at the center of the structure. The 
interdomain linker is depicted as a line (dashed line if it is partially disordered in the crystal 
structure) (Chen, et al., 2012). 
 
Two of the four substrate-binding pockets of RocR (C and D) are not 
accessible to c-di-GMP and thus likely to be constitutively enzymatically 
Chapter 1. Introduction 
 
 12 
inhibited. Inhibition of the enzymatic activity of the subunits C and D is 
achieved in trans by using the REC domains from the other two subunits to 
physically block the access of the c-di-GMP substrate. The EAL domains from 
the subunits A and B are likely to contain the functional active sites with open 
c-di-GMP binding pockets.  
The EAL domain of RocR adopt a (β/α)8 barrel-like fold (Chen, et al., 2012), 
confirming previous data; the catalytic residues are located at the C-terminal 
end of the barrel, including residues that form the metal ion binding site and 
the evolutionarily conserved residues of loop 6: D296FGAGYSS303. This motif 
seems to play an important role in signal transduction; sequence analysis of the 
5,862 EAL domains in the bacterial genomes revealed that about half of the 
EAL domains harbour a degenerated loop 6, suggesting that the mutation of 
this loop may indicate a divergence of function for EAL domains during 
evolution (Rao, et al., 2009). 
Moreover, as predicted by the structural model of RocR (Rao, et al., 2008), 
hydrolysis of one O-3’-P ester bond to yield the linear dinucleotide 5’-pGpG is 
achieved by an activated water molecule and involves one or two Mg2+ or 
Mn2+ ions and seven catalytic residues, including the Glu residue of the EAL 
signature motif.  
In contrast to EAL-domain PDEs, only one structure is available to date for 
HD-GYP containing proteins, which have so far resisted high-resolution 
crystallography. This domain is widespread in bacteria (over 1000 genes have 
been found); it is classified as a metal-dependent phosphohydrolase and a 
divalent cation (most likely Mg2+ or Mn2+) is required for catalysis, but the 
molecular mechanism of action is still unknown. Lovering and co-workers 
recently solved the first structure of Bd1817, an unconventional HD-GYP 
protein from predatory bacterium Bdellovibrio bacteriovorus (Lovering, et al., 
2011). Bd1817 present an uncharacterized N-terminal domain (NTD), and the 
C-terminal HD-GYP phosphodiesterase domain that lacks the active-site 
tyrosine present in most HD-GYP family members. Nevertheless it yet remains 
an excellent structural model, sharing 48% sequence similarity with the family 
archetype RpfG (from Xanthomonas campestris) (Lovering, et al., 2011). The 
crystal structure of Bd1817 reveals the presence of a binuclear iron center into 
the active site (fig. 1.6) Sequence alignment of Bd1817 with other HD-GYP-
containing proteins reveals that the majority of conserved residues cluster 
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around the binuclear metal centre, which is observed complexed to a molecule 
of phosphate. The fold and active site of the HD-GYP domain are different 
from those of EAL proteins, and restricted access to the active-site cleft is 
indicative of a different mode of activity regulation.  
 
Figure 1.6. Modular nature of the Bd1817 HD-GYP protein and active-site coordination of 
metal ions. Selected side chains and bound phosphate are shown in stick form, and metal ions 
and bound hydroxide (red, W1) are shown in sphere form. A) Ribbon diagram of Bd1817 
with individual domains colored separately as follows: NTD, blue; linker helices, yellow; HD-
GYP domain, white; lid region subdomain, green; GYP motif subdomain, orange. B) Detail of 
binuclear metal active site (HD-GYP domain). Fe-protein interactions, purple dashed lines; 
hydroxide-protein interaction, green dashed line (Lovering, et al., 2011). 
 
The region encompassing the GYP motif has a novel conformation and is 
surface exposed and available for complexation with binding partners, including 
GGDEF proteins (Lovering, et al., 2011), as seen for the RpfG (Ryan and Dow, 
2010). RpfG and the sensor kinase RpfC compose a two-component system 
implied in sensing and responding to the diffusible signalling factor (DSF), which 
is essential for cell-cell signalling (Barber, et al., 1997; Dow, et al., 2003; Ryan, et 
al., 2006; Slater, et al., 2000). Mutation in rpfG gene leads to a reduction in the 
synthesis of virulence factor (including extracellular enzymes), alteration in 
biofilm formation, reduced pilus dependent motility and reduction in virulence 
(Ryan, et al., 2010). However, the availability of more structures would allow a 
greater understanding of HD-GYP catalytic mechanism for c-di-GMP 
hydrolysis. 
In P. aeruginosa 3 genes harbour HD-GYP domain proteins: PA4108, PA4781 
and PA2572. The first two proteins control the swarming motility and the 
production of virulence factors and show to have a PDE activity in vivo, indeed 
their mutation leads to increased levels of c-di-GMP (Ryan, et al., 2009). On 
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the other hand, the role of the third protein PA2572 (which has a different 
YN-GYP signature) is uncertain (Ryan, et al., 2009): this protein is inactive in c-
di-GMP hydrolysis and it has a cryptic negative influence on swarming. 
Nevertheless, all three proteins regulate virulence of P. aeruginosa since their 
mutation led to a reduction of the bacterial virulence in the larvae of Galleria 
mellonella (Ryan, et al., 2009). Due to their importance in virulence and since 
the biochemical and structural information about HD-GYP are still poor, a 
deep characterization of this class of proteins is highly desirable.  
 
 
Table 1.1. Effects of HD-GYP genes deletion in P. aeruginosa strains compared to wild-type 
strain PAO1. 
 
The metabolic network involving c-di-GMP is highly complex and the exact 
molecular mechanism of c-di-GMP action remain to be fully elucidated. A 
detailed understanding of such complex regulatory mechanism will not only 
help to explain the specificity of c-di-GMP signalling systems, but may also 
favour a biotechnological research aimed to develop new strategies to fight 
biofilm in medical/industrial/environmental settings (Castiglione, et al., 2011; 
Wood, et al., 2011). Moreover, a great deal of research is still needed to use 
the c-di-GMP as a potential vaccine adjuvant in human clinical trials. 
Understanding how microbes control c-di-GMP metabolism to activate specific 
pathways is complicated by the apparent multifold redundancy of enzymes 
involved in the synthesis, degradation and/or binding of this crucial second 
messenger. Moreover, the mechanisms by which c-di-GMP exerts its regulatory 
effect are incompletely understood, probably due also to the evidence that c-
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di-GMP present a rich polymorphism in association with effectors (Yang, et al., 
2011) and in solution (Zhang, et al., 2004; Zhang, et al., 2006).  
 
Heterogeneity of c-di-GMP binding to proteins 
The mechanisms by which c-di-GMP exerts its regulatory effect are not 
completely understood. As mentioned above, also when bound to proteins, 
several distinct c-di-GMP conformations have been found, including the 
monomeric (Minasov, et al., 2009; Navarro, et al., 2009; Wang, et al., 2011) and 
the self-intercalated dimeric form (Benach, et al., 2007; Duvel, et al., 2012; Ko, 
et al., 2010). A wide variety of different protein-based or RNA-based 
recognition motifs for c-di-GMP have been discovered, including the 
transcription factor Clp (Chin, et al., 2010), RNA-processing polynucleotide 
phosphorylase (PNPase; (Tuckerman, et al., 2011)), inhibitory site of DGC 
protein (Schirmer and Jenal, 2009), degenerate GGDEF- or EAL-domain 
proteins (Navarro, et al., 2011), PilZ-domain proteins (Benach, et al., 2007; Li, 
et al., 2009) and riboswitches (Smith, et al., 2011) The binding of c-di-GMP 
self-intercalated dimer to the PleD and WspR allosteric I sites, comprising an 
RxxD motif and other less conserved secondary inhibition residues, has been 
shown to allow the DGC activity inhibition (Schirmer and Jenal, 2009). 
However, it is important to note that a recent computational analysis of 867 
prokaryotic genomes revealed that approximately half of over 10 000 GGDEF 
sequences lack the canonical allosteric inhibition sites (Seshasayee, et al., 2010). 
Whether these significant numbers of GGDEF-domain proteins are also 
subject to product inhibition and how this is achieved remain largely unknown. 
Very recently, Yang and co-workers report the structure of the GGDEF 
domain of an X. campestris diguanylate cyclase (XCC4471) in complex with c-
di-GMP (Yang, et al., 2011). Unexpectly, the structure of the complex indicates 
that two molecules of c-di-GMP reside in the GGDEF active site. Each c-di-
GMP molecule is also found to adopt an unusual partially intercalated 
conformation, different to that adopted by c-di-GMP binding the allosteric 
inhibitory sites (Yang, et al., 2011), which adopts a self-intercalated stack 
comprising four guanine bases. Such a novel GGDEF–c-di-GMP complex 
structure implies the existence of an unusual product bound mode for DGCs.  
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c-di-GMP polymorphism in solution and detection strategy 
It is known that c-di-GMP displays a rich polymorphism in solution, and that 
the equilibrium among the monomeric, dimeric, tetrameric and octameric 
species is affected by the presence of metal ions (Gentner, et al., 2012; Zhang, 
et al., 2004; Zhang, et al., 2006). However, only the monomeric and dimeric 
forms (fig. 1.7) have been found under physiological conditions, while higher 
oligomer formation occurs only at mM concentration or in presence of 
additional aromatic intercalators (Nakayama, et al., 2011; Nakayama, et al., 
2011). The monomer-dimer equilibrium is also likely to play a physiological 
role, allowing bacteria to sense and control different local c-di-GMP 
concentrations. Indeed PilZ receptors binding to c-di-GMP as a monomer or as 
an intercalated dimer have been reported (Benach, et al., 2007; Duvel, et al., 
2012; Ko, et al., 2010). The dimeric form is also observed in complex with 
DGCs, bound to a non competitive inhibitory site (De, et al., 2008; Yang, et al., 
2011), while PDEs bind c-di-GMP as a monomer at the active site (Minasov, et 
al., 2009; Navarro, et al., 2009; Wang, et al., 2011).  
 
Figure 1.7. Chemical structure of c-di-GMP and 3D structure of monomeric and dimeric c-di-
GMP as observed in the active and inhibitory site of PleD, respectively (PDB id: 1w25) (Chan, 
et al., 2004). The equilibrium in solution of the two species is affected by the presence of 
monovalent or divalent cations (Gentner, et al., 2012; Zhang, et al., 2004; Zhang, et al., 2006) 
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However, the dearth of detailed information regarding c-di-GMP signalling is 
probably also  dueto the lack of a rapid and unexpensive experimental strategy 
to readily detect c-di-GMP. Indeed, despite the great effort in understanding 
the molecular basis of the c-di-GMP signalling pathways and the growing 
number of groups working in this field, a method for in vitro detection and 
quantification of c-di-GMP is still not available for reliable real-time 
measurements. Current direct c-di-GMP detection methods rely on the use of 
analytical techniques, like reverse phase HPLC and mass spectrometry 
(Antoniani, et al., 2009; Simm, et al., 2009; Spangler, et al., 2010), which require 
a complex and time consuming sample preparation, since small molecules need 
to be separated from macromolecules before analysis. Furthermore, mass 
spectrometry is not always readily available in many biochemistry and 
molecular biology labs. Thin layer chromatography, although being a semi-
quantitative technique, could be a fast alternative method, but it carries the 
disadvantage of requiring radiolabeled nucleotides as substrates, given the low 
concentration of c-di-GMP that are usually detected in enzymatic studies (low 
µM range). The use of the EnzChek® Pyrophosphate Assay Kit has also been 
reported (De, et al., 2008). This is an indirect method based on several 
enzymatic reactions to quantify the inorganic pyrophosphate (PPi) produced as 
side product in the synthesis of c-di-GMP by diguanylate cyclases. Recently, 
new spectroscopic methods have been reported:  one method is based on the 
ability of c-di-GMP to form tetramers with a G-quadruplex-like structure in the 
presence of specific dyes (Nakayama, et al., 2011). This method is limited by 
the dyes solubility and by the extremely slow kinetics (>10 hours at 4°C) of 
complex formation between c-di-GMP quadruplex and the dye. Moreover, in 
our hands, it showed a non linear dependence with the c-di-GMP 
concentration in the low µM range (data not shown), possibly given that the 
multiple equilibrium between monomeric, dimeric and tetrameric c-di-GMP is 
strongly affected by the initial monomer concentration (Gentner, et al., 2012). 
Fluorescence-based detection of c-di-GMP has been recently proposed using 
either an RNA-based aptamer (Nakayama, et al., 2012) or a fluorescent 
derivative of c-di-GMP (Sharma, et al., 2012); although fluorescence guarantees 
high sensitivity to these approaches, limitations related to long pre-incubation 
times or side-effects such as inhibition of the enzymes suggest that they are 
more suitable for binding studies than for kinetic real-time measurements of 
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both DGCs and PDEs. An indirect method has also been proposed based on 
the ability of the c-di-GMP G-quadruplex to enhance hemin peroxidation in 
the presence of proflavine (Nakayama, et al., 2012). This strategy, however, is 
unlikely to be useful for real-time quantification of c-di-GMP since it involves 
redox reactions, which may damage or interfere with the stability of the 
enzymes producing or consuming c-di-GMP. 
The availability of a direct experimental strategy to detect and quantify c-di-
GMP could provide significant advances and important clues to direct future 
experimental work on enzymes able to synthesize and degrade c-di-GMP. 
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AIM OF THE WORK 
 
Bacteria are not only simple single-cell organisms inhabiting our world but they 
are able to communicate and behave like a multicellular organism forming 
biofilms. 
The impact of biofilms on human health is huge: more than 60% of all 
infections in developed countries are caused by bacterial biofilms. These 
bacterial communities are difficult to eradicate since they are highly resistant to 
antimicrobials and to the host immune system. The scientific challenge is 
therefore to find new therapeutic options, which specifically target bacteria 
growing in biofilms. 
Biofilm formation is a complex event: it implies the transition from the 
planktonic to the sessile way of life. One of the most important signal involved 
in controlling biofilm formation is the intracellular second messenger 3',5'-cyclic 
diguanylic acid (c-di-GMP); moreover c-di-GMP is involved in the mechanism 
by which immune system can detect bacterial infection. Therefore, targeting c-
di-GMP metabolism could represent an attractive strategy for the development 
of novel therapeutic approaches against bacterial biofilm. 
The aim of this PhD project is to gain mechanistic insights on the enzymes 
involved in the c-di-GMP signalling system, in order to contribute to the search 
for novel anti-biofilm compounds. 
Our model organism is the human pathogen Pseudomonas aeruginosa, leading 
agent of nosocomial infections and the main cause of death in patients affected 
by cystic fibrosis (CF), a genetic disease affecting 1/3000 newborns in Europe. 
Several evidences suggest that the c-di-GMP signalling pathway is important for 
P. aeruginosa biofilm establishment and persistence, but the molecular 
mechanisms controlling this bacterial process leading to biofilm formation 
during cystic fibrosis infections are still largely unknown. 
This project has been divided into two major tasks: 
(1) Biochemistry of selected HD-GYP proteins involved in c-di-
GMP hydrolysis - In the framework of broader research project ongoing in 
my group and focused on the metabolism of c-di-GMP in P. aeruginosa, the 
present study aims at analyzing the catalytic mechanism of selected HD-GYP 
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phosphodiesterases, whose involvement in biofilm formation and virulence has 
been already demonstrated (Ryan, et al., 2009). More in detail, we have 
analyzed the HD-GYP proteins encoded by the PA4781 and PA4108 genes.  
Beyond the catalytic HD-GYP domain, these enzymes contain a CheY-like or 
an uncharacterized domain, respectively, at the N-terminus. These domains are 
presumably involved in the regulation of the catalysis; this aspect has been 
analyzed in particular for PA4781. 
(2) Development of medium throughput assay for c-di-GMP 
quanti f ication - The kinetic characterization, needed to pursue the goal 
described above, requires a reliable enzymatic assay able to quantify the 
nucleotide content along the reaction time-course.   
It should be mentioned that, despite the relevance of the c-di-GMP signalling, 
to date, the continuous and prompt measurement of c-di-GMP (enzymatically 
produced/consumed) is demanding and difficult to be carried out with the 
quantification methods available. This constrain could represent also a limiting 
step for future screening of a large number of putative inhibitors of diguanylate 
cyclases or phosphodiesterases.  
For this reason we have set up a novel Circular Dicroism (CD) assay for rapid 
spectroscopic quantification of c-di-GMP levels, based on the capability of the 
manganese ion to promote c-di-GMP dimerization; this species displays a 
peculiar circular dichroism signal which is linearly dependent on c-di-GMP 
concentration. 
 
The knowledge gained in the present study allowed us to obtain novel data on 
these P.aeruginosa HD-GYP proteins; moreover, the experiments carried out 
for the HD-GYP project and for the set up of the novel kinetic assay will be 
crucial for the characterization of other PDEs and DGCs relevant to 
pathogenesis in other microrganisms.  
The data presented here will be extended in the future in order to find a 
strategy capable to target selectively c-di-GMP metabolism, to be used also in 
combination with traditional antimicrobial therapies, given that there is no 
compound on the market able to specifically interfere with biofilm formation. 
Since biofilm-mediated infections are wide-diffused, the potential therapeutic 
impact deriving from the inhibition of biofilm via c-di-GMP in several human 
diseases is huge. 
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METHODS 
 
3.1 HD-GYP characterization 
Cloning and site-direct mutagenesis 
Synthetic PA4781 and PA4108 genes were purchased from Geneart 
subcloned into the Pet28b and Pet24 vector in frame with a N-terminal and C-
terminal His-tag, respectively (GENEART). A truncated version of PA4781 
(hereinafter PA4781G) was produced by PCR, starting from PA4781 as 
template, in order to remove the first 111 residues, corresponding to the REC 
domain. The corresponding fragment was then cloned into the NdeI and XhoI 
restriction sites of pet28. 
Mutation of Phe290 into Tyr was performed with the QuikChange 
mutagenesis kit (Stratagene), according to the manufacturer's instructions, on 
both pet28-PA4781 or pet28-PA4781G templates (the residues number refer 
to the full length sequence).  
  
Proteins expression and purification  
For each vector, protein expression was obtained after transformation of E. coli 
BL21 (DE3) strain. Overnight cultures were used to inoculate (1:100) 400 ml 
of liquid Luria-Bertani broth with Kanamycin (30mg/ml) and 0,1 mM IPTG 
(isopropyl B-d-thiogalactoside). Cultures were grown under constant shaking at 
37°C (full-length proteins) or 25°C (PA4781Gstart mutant) until the cells 
reached late-exponential phase (OD600= 0,8-1,0). Cells were harvested by 
centrifugation and resuspended in lysis buffer (50mM TRIS pH 8, 50mM NaCl, 
1mM PMSF). In order to increase the expression and the solubility of PA4108 
protein, the expression was also carried out in BL21plysS (DE3) E. coli strain 
under constant shaking at 37°C; protein expression was induced with 1 mM 
IPTG when OD600 was 0,7. Cells were harvested by centrifugation after 2h and 
the protein was purified as described below. 
Cell lysis has been carried out by ultrasonic treatment on ice and the cleared 
soluble extract was obtained by centrifugation. Proteins were purified as His-
tagged fusion using a 5ml HisTrap column (GE Healtcare) equilibrated with 
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buffer A (20 mM TRIS pH 7.6, 150 mM NaCl). Eluition has been carried out 
with a stepwise increase in imidazole concentration, with all proteins eluting at 
200mM imidazole. The buffer exchange of pooled fractions was performed 
with PD-10 Desalting column (GE Healtcare). The aggregation state of the 
proteins was analyzed with a Superdex-75 10/30 column equilibrated with 
buffer A, using a HPLC apparatus.  
 
Phosphodiesterase activity assay on purified proteins 
c-di-GMP and pGpG hydrolysis - The ability of the aforementioned 
proteins to hydrolyze c-di-GMP, was assayed incubating the proteins (110 µg 
of purified PA4781 full-length and of PA4781G; 10 µg of PA4108) four hours 
at 30°C in the reaction buffer (50 mM Tris–HCl pH 8, 150 mM NaCl) in the 
presence of 2,5 mM MnCl2, and/or 10 mM MgCl2 and 30 µM c-di-GMP or 
pGpG (BIOLOG) as substrate. The reaction was stopped boiling the sample 
for 10 min; the precipitated protein was removed with 0,2 µm filters (Bilk GHP 
Acrodisc 13mm). At least two independent assays for each sample were 
performed; protein storage buffer was used as negative control.  
The nucleotide content of the samples was measured by HPLC analysis using a 
150 x 4.6 mm reverse phase column (Prevail C8, Grace Davison Discovery 
Science) at room temperature on a LabFlow 4000 apparatus (LabService 
Analytica). Detection wavelength was 252 nm and mobile phase was 100 mM 
phosphate buffer pH 5.8 / methanol (98/2, v/v). Synthetic c-di-GMP, pGpG 
(Biolog) and GMP (GE Healtcare) were used as standard.  
Determination of kinetic parameters of PA4108- The initial velocity 
at given substrate concentration was obtained by analyzing aliquots of the 
reaction mixture at different times. The initial velocity was measured at 4 
substrate concentrations (10, 60, 150, 300 µM c-di-GMP). The Km value was 
obtained by fitting the initial velocities obtained at various substrate 
concentrations with the Michaelis-Menten equation, using the software Igor 
Pro. 
Activation of PA4781 by BeF3
- modi fication - PA4781 was incubated 
at room temperature in reaction buffer with beryllium fluoride (BeF3
-) for at 
least 30 min before substrate addition, according to Paul et al. 2007. The assay 
was performed at several BeCl2 concentrations (0, 0.1, 0.15, 0.2, 0.3, 0.5, 1, 1.5, 
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2.5, 5 mM) in the presence of 10 mM NaF, and subsequently at several NaF 
concentrations (0, 0.3, 0.5, 0.8, 1, 1.5, 2, 2.5, 5, 10 mM) in the presence of 0.15 
mM BeCl2. 
 
Isothermal Titration Calorimetry (ITC)   
ITC experiment was carried out using an iTC200 microcalorimeter (MicroCal). 
A PA4781 solution was prepared in 100 mM Tris (pH 8.5), 50 mM NaCl, 10 
mM MgCl2 and 2.5 mM MnCl2. c-di-GMP solution was prepared by dilution of 
a 1mM stock solution (in water) with PA4781 buffer. 2-µl aliquots of c-di-GMP 
solution (80 µM) were injected into a 3 µM protein solution at 25°C. Data 
were fitted using the “one-binding-site model” of the MicroCal version of 
ORIGIN. The heat of binding (ΔH), the stoichiometry (n), and the dissociation 
constant (KD) calculated from the plot of the heat evolved per mole of ligand 
injected versus the molar ratio of ligand to protein presents high errors of fit, 
being very low the affinity of binding. 
Determination of intracellular c-di-GMP content  
The E.coli strain (AB1548: AB472∆yhjH) lacking the endogenous PDE yhjH (a 
kind gift of Dr A. Boehm), was used to perform the PA4108, PA4781 and 
PA4781G complementation assays. This strain, which presents high level of c-
di-GMP, was also transformed with the pet28b control vector, as negative 
control. Cultures were grown at 37°C in LB medium, 0,1 mM IPTG was added 
when OD was 0.8 and cells were harvested by centrifugation after 2 hours of 
further growth. Soluble cell extract was prepared as previously described 
(Antoniani, et al., 2009) and the nucleotide content was analyzed by C8 
reverse-phase column (Prevail 150x4.6mm, 5µm). Wild-type strain (MG1655) 
was used as reference of normal c-di-GMP levels. 
 
Phosphodiesterase activity assay on soluble cell extracts 
E.coli wild-type strain (BL21 (DE3)) overexpressing PA4781 or PA4781Gstart 
or PA4108 was used to analyze the PDE activity of these proteins in soluble 
cell extract. Cultures were grown in 25 ml of growth medium under constant 
shaking at 37°C until the cells reached late-exponential phase (OD600= 0,8-
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1,0). E.coli strain containing pET28 vector was grown under the same 
conditions, as control. Cells were harvested by centrifugation and resuspended 
in 4 ml of PDE buffer (50 mM Tris-HCl pH 8.0, 10 mM MgCl2, 250 mM NaCl, 
5 mM 2-mercaptoethanol, 1 mM PMSF, Complete EDTA-free protease 
inhibitor (Roche Diagnostics, Indianapolis)) and frozen overnight at -80°C, 
according to (Kulasakara, et al., 2006). Cultures were than thawed on ice and 
sonicated. Synthetic c-di-GMP (final concentration 10 µM) was added to each 
lysate, and the reaction was allowed to proceed for 3.5 h at 30°C. The 
reaction was stopped by the addition of 2 ml of 1 M HClO4 and, after 
neutralization with 2 M K2CO3 each sample was centrifugated (Kulasakara, et 
al., 2006). The supernatant was evaporated to dryness using a Speed Vac, 
resuspended in 500 µl of HPLC-running buffer (100mM NaPhO pH 5.8), 
filtered with 2µm filters and analyzed by HPLC, as described above. We 
performed at least two independent assays for each sample and c-di-GMP 
peak in each sample was compared with that detected in the extract from the 
control strain, after incubation whit c-di-GMP, as described above. 
 
3.2 New strategy for c-di-GMP detection and 
quantification.  
General methods  
CD experiments were carried out using quartz cuvettes (Hellma) with a path 
length of 1 cm on a JASCO J-710 spectropolarimeter. Spectra were baseline 
corrected by subtracting the buffer from the raw data and the signal was 
adjusted to zero at 340 nm as no optical activity is expected at this wavelength. 
HPLC analysis was performed as described above. 
 
Influence of metal ions on c-di-GMP 
 To verify the influence of metal ions on the c-di-GMP dimer formation, 
samples containing 15 µM c-di-GMP (Biolog) in 20 mM Tris pH 8 and 100 mM 
NaCl were analyzed in the presence of 2.5-10 mM of MnCl2, and/or MgCl2. 
CD spectra were measured at 10°C. To obtain the calibration curves, 
increasing concentrations of c-di-GMP (1, 5, 10, 15, 20, 25  and 30 µM) in 20 
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mM Tris pH 8, 100 mM NaCl, 10 mM MgCl2, 1 mM BeCl2, 10 mM NaF and 
2.5 mM MnCl2 (reaction buffer of PleD) were analyzed. The same profile is 
obtained in the absence of BeF3
- (data not shown). CD analysis was performed 
in duplicates at 10°C, 25°C and 37°C. 
 
Analysis of manganese affinity for c-di-GMP 
Increasing concentrations of MnCl2 (0.2 to 15 mM) were added to a sample 
containing 15 µM c-di-GMP (Biolog) in 50 mM Tris pH 7.5, 150 mM NaCl and 
10 mM MgCl2. CD spectra were recorded at 10°C after allowing the samples 
to equilibrate for 10 minutes. A KD of 262 ± 36 µM for the c-di-GMP-Mn2+ 
complex was calculated by fitting the observed CD282 signal as a function of 
MnCl2 concentration. 
 
CD spectra of other nucleotides 
The CD spectra of 15 µM pGpG (Biolog), c-di-GMP, GMP (Sigma Aldrich) and 
GTP (Amersham Bioscience) and c-di-AMP (Biolog) were recorded in 50 mM 
Tris pH 8, 150 mM NaCl, 10 mM MgCl2 and 2.5 mM MnCl2. The spectra vary 
slightly with buffer conditions. The concentration of stock solutions of GTP and 
GMP was determined by measuring the absorption at 253 nm using 13,700 M-1 
cm-1 and 13,300 M-1 cm-1 as molar extinction coefficients.  
 
Kinetic studies  
To study the diguanylate cyclase activity of purified Caulobacter crescentus PleD, 
a 0.5 µM enzyme solution was incubated for 10 minutes at room temperature 
in 20 mM Tris pH 8, 100 mM NaCl, 10 mM MgCl2. The enzyme was then 
activated by adding 1 mM BeCl2 and 10 mM NaF and kept at room 
temperature for 30 minutes. The diguanylate cyclase reaction was performed 
at 20°C in the presence of 2.5 mM MnCl2 and was started by adding 100 µM 
GTP; the time course of the reaction was followed by directly measuring the 
CD signal at 282 nm. In parallel, the reaction was followed under the same 
experimental conditions but aliquots were taken at different times (1, 3, 5, 10, 
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30 and 60 min), samples were boiled for 10 min to stop the enzymatic 
reaction, spun down and filtered to remove the precipitated protein. The 
samples were then analyzed both by CD spectroscopy at 20°C and by reverse 
phase HPLC as described above. The experiment was performed in duplicate. 
PleD was purified as previously described by Wassmann and coll. (Wassmann, 
et al., 2007). The enzymatic activity of Beryllium-activated PleD was found to 
be 20 nmol/min/mg, in good agreement with the value previously published 
(Paul, et al., 2004) (Paul, et al., 2007). 
To study the phosphodiesterase activity of Pseudomonas aeruginosa RocR, a 0.5 
µM enzyme solution was incubated for 10 minutes at room temperature in 20 
mM Tris pH 8, 100 mM NaCl, 5 mM MgCl2, 2.5 mM MnCl2. The reaction was 
performed at 20°C and was started by adding 30 µM c-di-GMP. The enzymatic 
reaction was followed in real-time at 282nm. In parallel, aliquots were taken at 
different times (3, 5, 15, 30 and 45 min), and 100mM CaCl2 or 25mM EDTA 
pH 6.0 were added to stop the enzymatic reaction; samples were boiled for 10 
min, spun down and filtered to remove the precipitated protein. Samples were 
then analyzed by CD spectroscopy at 20°C and by RP-HPLC. The experiment 
was performed in duplicate. RocR was expressed in BL21(DE3) strain 
transformed with pProExHTb-RocR (a kind gift of Prof. H. Sondermann, CH) 
and purified as previously described by De and coworkers (De, et al., 2008). 
The turnover number of RocR was found to be 0.1 s-1, somewhat slower than 
the value previously published (0.67 s-1), in which the activity was measured by 
following the production of pGpG at 23°C in the presence of 25 mM MgCl2 
(Rao, et al., 2008); this difference is not surprising given the different 
experimental conditions employed in the present work (lower temperature 
and MgCl2 concentration). 
To analyze by CD spectroscopy the phosphodiesterase activity of PA4781 the 
sample was prepared as previously described for HPLC analysis; the enzymatic 
reaction was followed at 30°C in real-time at 282nm.  
Titration of PleD with c-di-GMP.  
To study the binding of c-di-GMP to PleD, increasing concentrations of c-di-
GMP were added to a sample containing 10 µM of PleD in 20 mM Tris pH 8, 
100 mM NaCl, 10 mM MgCl2, 1 mM BeCl2, 10 mM NaF. CD spectra were 
taken at 25°C after equilibration of the system. The spectra of the samples 
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containing 25, 30, 35 and 40 µM c-di-GMP were measured again after the 
addition of MnCl2 to a final concentration of 2.5 mM. The order of addition of 
the three components in the mixture (i.e. PleD+c-di-GMP+Mn2+ or c-di-
GMP+PleD+Mn2+ or c-di-GMP+PleD+Mn2+) did not change the final 
spectrum (data not shown). The experiment was performed in triplicate. The 
experiment was performed in triplicate. 
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RESULTS and DISCUSSION 
 
4.1 HD-GYP characterization 
Previous in vivo studies (Ryan, et al., 2009) have shown that two HD-GYP 
proteins from P.aeruginosa, PA4781 and PA4108 (see tab 1.1), are involved in 
the control of swarming motility and production of virulence factors, leading to 
increased levels of c-di-GMP in mutant strains (Ryan, et al., 2009). In order to 
get a deeper insight into these HD-GYP-mediated responses and their reaction 
mechanism, we decided to characterize in vitro the PDE activity of both 
PA4781 and PA4108, produced as recombinant proteins expressed in E.coli.  
The characterization of phosphodiesterase activity requires the analysis of 
nucleotide content in the reaction mixture, which can be carried out by 
different methods (discussed in more detail later). One of the widely used 
approach for studying both DGCs and PDEs is based on the reverse phase 
chromatography. Basically, an aliquot of the reaction is analysed through this 
technique at different times, following the removal of the protein content (by 
boiling and filtration). The c-di-GMP detection method was set up and 
implemented in the group during the first part of my PhD. 
 
Optimization of reverse phase chromatography method 
In order to optimize the nucleotide separation by HPLC on a c8 reverse phase 
column, several elution buffers were tested. The retenction time of GMP (GE 
healtcare), pGpG (biolog) and c-di-GMP (biolog) was assayed using as mobile 
phase different concentrations of sodium phosphate buffer (NaPhO) mixed 
with several concentrations of methanol or acetonitrile. The optimum 
separation was obtained by mixing 98% of 100 mM NaPhO pH 5.8 (buffer A) 
and 2% Methanol absolute (buffer B) (fig. 4.1A).  
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.  
Figure 4.1. A) HPLC profile of GMP, pGpG and GMP; B,C and D) nucleotides calibration 
curves. 
 
Different concentrations of these nucleotides were than analyzed under these 
elution conditions (fig. 4.1, B,C and D panels), in order to obtain a linear 
correlation between peak area and the nucleotide concentration. These 
calibration curves were used to quantify the content of these nucleotides 
during the characterization of the enzymatic c-di-GMP hydrolysis. 
PA4108 
Puri fication and preliminary character ization - PA4108 is composed 
by a HD-GYP catalytic domain and by an uncharacterized domain (NTD) 
located at the N-terminus of the protein (fig. 4.2).  
 
 
Figure 4.2. PA4108 domain organization: N-terminal uncharacterized domain (NTD) and C-
terminal HD-GYP catalytic domain. 
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Synthetic PA4108 gene was purchased from Geneart subcloned into the 
Pet24b vector in frame with 6xHistidine tail at the C- terminal of the protein 
(pET-PA4781-HIS). Initially, the BL21(DE3) E. coli strain was transformed with 
the pET-PA4781-HIS plasmid and the protein was expressed in the presence 
of 0,1 mM IPTG; bacterial growth was stopped in the mid-log phase, since the 
prolonged over-expression of this protein strongly slowed down the 
exponential phase of cellular growth. This behaviour may suggest that this 
protein could be involved in the regulation of bacterial cell cycle. Under these 
growth conditions, we obtained very low yield of purified protein (0,006 mg/l), 
which presents a very low solubility. 
In order to obtain higher levels of soluble protein, the expression was also 
carried out in BL21plysS (DE3) E. coli strain; this expression condition was 
choose to purify PA4108, even though also in this background, low yield of 
purified protein (2 mg/l) was obtained.  
The analysis of the aggregation state of purified PA4108, obtained by gel 
filtration chromatography in 20 mM TRIS pH 7.6, 150 mM NaCl (fig. 4.3A), 
revealed that PA4108 is mainly a monomer in solution and that higher 
aggregation states are not significantly populated.  
 
 
Figure 4.3. A) PA4108 gel filtration profile (superdex 75): the elution volume was 11,84 ml 
corresponding to a molecular weight of 45kDa, indicating that PA4108 is mainly a monomer in 
solution. B) UV-spectrum (250-340nm): the high absorption contribution below 270 nm is 
typical of nucleotide species. 
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The spectroscopic analysis of purified PA4108 has shown an UV-Vis spectrum 
(250-340 nm) with a broadened peak ranging between 260-280 nm (fig. 4.3B), 
with high absorption contribution below 270 nm, typical of nucleotide species. 
It is, indeed, reported in the literature that proteins involved in c-di-GMP 
turnover are purified in association with this nucleotide (De, et al., 2009; Paul, 
et al., 2007); it is not excluded that, also in the case of PA4108, a fraction of c-
di-GMP co-purified with the protein. In order to verify this hypothesis, the 
protein content was removed by boiling the sample and the nucleotide 
content was analyzed by reverse phase HPLC. A small but significative amount 
of c-di-GMP and pGpG was observed, thus demonstrating that a small fraction 
of the protein (~4%) was purified in complex with these nucleotides.  
Pde activ i ty assays - As mentioned in the introduction, PDEs require metal 
ions for the phosphodiester hydrolysis (Christen, et al., 2005). For this reason, 
we first tested the c-di-GMP hydrolytic activity incubating the purified PA4108 
for 4 hours with excess of substrate in the presence of Mg2+ and/or Mn2+, since 
a large number of enzyme involved in c-di-GMP synthesis and degradation 
need these metal ions to be catalytically active. The analysis of nucleotide 
content, performed by reverse phase HPLC, revealed that PA4108 need both 
Mg2+ and Mn2+ to hydrolyze c-di-GMP (tab. 4.1). Moreover several pH (7.5-9) 
and temperature (25-37°C) were tested, identifying the optimum at pH 8 at 
30°C. 
 
Metal ion c-di-GMP hydrolyzed (µM) 
2,5 mM Mn2+ 1,46 
10mM Mg2+ 1,58 
2,5mM Mn2++ 10mM Mg2+ 2,3 
Talbe 4.1: c-di-GMP hydrolysis in the presence of different metal ions. PA4108 (0,73µM) was 
incubated for four hours at 30°C with 30µM substrate. 
 
The c-di-GMP hydrolysis obtained under these experimental conditions 
demonstrates for the first time the activity of the purified PA4108 protein as c-
di-GMP PDE (fig. 4.4).  
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Figure 4.4. PA4108 c-di-GMP hydrolysis: 0.73 µM PA4108 incubated for 4 hours at 30°C with 
of 10 mM MgCl2 and 2,5 mM MnCl2.(bold line). As control the sample without the protein 
(dotted line) was also analysed. 
 
However, a low fraction of substrate was hydrolyzed after four hours of 
incubation suggesting that under these experimental conditions PA4108 
displayed a very low phosphodiesterase activity. In order to improve the 
hydrolysis of c-di-GMP, the KM parameter was determined by analyzing the 
time course of c-di-GMP hydrolysis at different substrate concentrations (10, 
60, 150, 300 µM c-di-GMP) (fig. 4.5). These experiments revealed that the KM 
for c-di-GMP is ~160 µM, a value significantly higher than that typical of other 
catalytically active enzymes (for example RocR KM=3,3 µM (Rao, et al., 2008)). 
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Figure 4.5. Plot of the initial rate of c-di-GMP hydrolysis measured at different c-di-GMP 
concentration (black circles). Date were then fitted with the Michaelis Menten equation 
(continous line) in other to extrapolate the Km and Vmax (8•10-3 µM/min) parameters  
 
As mentioned in the introduction, the final product of c-di-GMP hydrolysis 
catalyzed by PDE-EAL subclass is pGpG (Hengge, 2009); this nucleotide 
undergoes further degradation by non-specific hydrolases in the cell. On the 
other hand, it has been attributed to the PDE-HD-GYP subclass capability to 
Chapter 4. Results and Discussion 
 
 34 
further hydrolyse pGpG to GMP (Ryan, et al., 2006) as confirmed also by our 
data (fig. 4.4); for this reason, it is not excluded that the HD-GYP proteins are 
able to hydrolyze exogenous pGpG used as a substrate. The hydrolytic activity 
of PA4108 toward pGpG was assayed using pGpG (30 µM) in the absence of 
c-di-GMP; the result indicates that a small fraction of pGpG was indeed 
converted in GMP, thus demonstrating that, although low, PA4108 does 
display a pGpG hydrolase activity (data not shown).  
 
PA4781 
PA4781 is composed by a HD-GYP catalytic domain and by a CheY-like 
regulatory domain (REC-domain) located at the N-terminus of the protein (fig. 
4.6). Synthetic PA4781 gene was purchased from Geneart subcloned into the 
Pet28b plasmid in frame with 6xHistidine tail at the N- terminal of the protein. 
 
 
Figure 4.6. PA4781 domain organization: N-terminal CheYlike regulatory domain (REC 
domain) and C-terminal HD-GYP catalytic domain 
 
Pur i fication and prel iminary character ization - The BL21(DE3) E. coli 
strain was transformed with pET-PA4781-HIS plasmid and the protein was 
expressed in the presence of 0,1 mM IPTG. Contrary to PA4108, the presence 
of the IPTG inducer from the beginning of the bacterial growth does not alter 
the growth profile, as compared to the control strain lacking the PA4781 gene. 
This setup allows us to purify to the homogeneity PA4781 in good yields (10 
mg/l). 
It was found by gel filtration chromatography that the protein is mainly in the 
monomeric state (fig 4.7A).  
The UV-Vis spectra (250-400 nm) of purified PA4781display a single peak at 
280 nm without any other peaks in the 250-260 nm range; this feature 
suggests that the purified protein does not contain a significant fraction of 
nucleotide species, contrary to PA4108 (fig. 4.7B). 
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Figure 4.7. A) PA4781 gel filtration profile (superdex 75): PA4781Mw=43kDa, the elution 
volume of 10,2 ml, corresponding to a molecular weight of ~60kDa, indicates that PA4781 is 
mainly a monomer in solution. B) UV-spectrum (250-340nm): no absorption peaks below 270 
nm. 
 
PDE activi ty assay - As described for PA4108, the enzymatic assays were 
carried out in the presence of Mg2+ and/or Mn2+ by incubating the protein for 
four hours with synthetic c-di-GMP and analysing the nucleotide content in the 
reaction mixture by reverse phase HPLC (see methods). The absence of peaks 
corresponding to the products in the resulting chromatograms indicated that 
no hydrolysis has occurred (not shown); this evidence suggests that, under 
these experimental conditions, PA4781 is not active. No hydrolytic activity was 
observed also using pGpG as substrate.  
A sequence alignment (fig 4.8) of several HD-GYP proteins revealed that 
PA4781 contains a suboptimal signature in the catalytic domain, being the 
canonical tyrosine in the GYP signature substituted with a phenylalanine 
residue in PA4781. It is not excluded that the presence of a suboptimal 
sequence in the GYP signature may account for the lack of catalytic activity 
observed with PA4781. For this reason, the phenylalanine residue (F290 in the 
sequence) in the GYP signature has been substituted with a tyrosine, by site-
directed mutagenesis and the enzymatic activity was assayed; despite the 
mutation, no c-di-GMP hydrolysis was observed, suggesting that the GYP 
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signature is not necessary or sufficient for catalysis (Lovering, et al., 2011; Ryan, 
et al., 2010).  
 
Figure 4.8. PA4781 sequence is indicated by black arrow. The GYP signature is indicated by 
blue triangles. Conserved residues are boxed in white font on a red background, and partially 
conserved residues are boxed in red font on a white background (Lovering, et al., 2011).  
 
As mentioned above, PA4781 presents a regulatory REC domain upstream the 
catalytic one that belongs to a class of domains which requires the transfer of a 
phosphoryl group onto a conserved Aspartic acid acceptor residue (Paul, et al., 
2007). In many two-component regulators, the unphosphorylated receiver 
domain restricts the effector domain in an unfavourable conformation which 
reverts to a favourable one upon phosphorylation of the REC domain (Gao 
and Stock, 2010). This evidence suggests that the presence of this domain and 
the need of activation by phosphorylation, could be the cause of the observed 
PA4781 inactivity. In order to trigger REC domain activation, PA4781 has been 
incubated with berillium floride (BeF3
-), a compound known to mimic the 
phosphoryl group (Paul, et al., 2007). PA4781 enzymatic activity was then 
assayed in the presence of different concentrations of BeF3
- (0,1-5 mM BeCl2 
and 0,3 -10 mM NaF); this setting does not activate the protein, thus suggesting 
that the mechanism of activation of the REC domain of PA4781 is more 
complex then that of other proteins (Paul, et al., 2007). The inactivity of 
PA4781 could be due to an inability to the recombinant form to bind the 
substrate c-di-GMP. The protein is indeed purified without any nucleotide 
bound, contrary to PA4108. The affinity for c-di-GMP was than probed by 
means of Isothermal Titration Calorimetry (ITC) approach (fig. 4.9), a 
technique which allows the determination of the thermodynamic profile of 
molecular interactions  
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Figure 4.9. Microcalorimetric titration of 3 µM PA4781 with 80 µM c-di-GMP. Upper panel: 
Raw ITC data. As previously published (Paul, et al., 2007), the calorimetric data obtained at 
very low c-di-GMP concentrations (first three injections) show a deviation from the simple 
binding model used to fit the data. This may be related to the varying degree of dimerization of 
c-di-GMP in solution (Paul, et al., 2007). As reported for PleD, since the peculiar effect due to 
c-di-GMP dilution is limited to the first few injections and does not interfere with the sigmoidal 
part of the binding curve, these points have been eliminated from the fit. Lower panel: 
Integrated peak areas (black circles) and fit with the one-binding-site model of ORIGIN 
provided by MicroCal (continuous line).  
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As described in figure 4.9, PA4781 binds c-di-GMP with very low affinity (KD > 
100 µM) and no catalysis has followed upon nucleotide addition (confirming 
HPLC data). In such a contest, the low affinity does not allow us to saturate 
the protein in the ITC experiment and, consequently, to extrapolate the exact 
parameters. However, this result may suggest that the conformation of the 
HD-GYP domain, where c-di-GMP hydrolysis should occur, is not optimal for 
substrate binding. It is not excluded that phosphorylation of the REC domain 
triggers a conformational change also in the catalytic one; this event may 
constitute an high-affinity binding site for c-di-GMP which allow PA4781 to 
enter a catalytic cycle. 
 
Characterization and enzymatic activi ty of PA4781G - In order to 
by-pass the limitation due to the REC domain activation, a truncated version of 
the protein lacking the entire REC domain has been produced by removing the 
first 111 residues (PA4781G) (fig. 4.10). 
 
 
Figure 4.10. PA4781G Domain organization: mutant lacking the regulatory REC domain. 
 
High yields of purified soluble PA4781G (9 mg/l) was obtained by growing the 
expression strain at 25 °C, in the presence of 0.1 mM IPTG. As previously 
observed for PA4108, the over-expression of this protein slowed down the 
exponential phase of cellular growth (8 hours compared to the 4 of the full-
length protein).  
It has been shown by gel filtration chromatography (fig. 4.11A) that the purified 
protein is mainly in the dimeric state.  
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Figure 4.11. A) PA4781G gel filtration profile (superdex 75): PA4781G Mw=31kDa, the 
elution volume of 10,26 ml correspondent to a molecular weight of ~60kDa, indicate that 
PA4781G is mainly a dimer in solution. B) UV-spectrum (250-340nm): high absorption 
contribution below 270 nm typical of nucleotide species. 
 
Interestingly UV-Vis spectra (250-400 nm) of purified PA4781G display a 
broadened peak ranging between 260-280 nm (fig. 4.11B); in agreement with 
previous hypothesis (see PA4108 characterization) the shape of this spectrum 
strongly suggests that the protein has been purified with nucleotides bound. 
The analysis of nucleotide content unveiled, indeed, that a small amount of 
pGpG and GMP was present, suggesting that a small fraction of the protein 
(~4%) binds both pGpG and GMP, contrary to PA4781 full length protein.  
The catalytic activity of PA4781G was assayed as reported above; little but 
significative hydrolysis of both c-di-GMP and pGpG was observed (fig. 4.12) 
suggesting that the absence of the REC domain promotes the PDE activity. 
This evidence confirms that the activation of the regulatory domain is 
necessary for the hydrolytic activity.  
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Figure 4.12. : Comparison of c-di-GMP hydrolytic activity of purified proteins. 
 
The substitution of phenylalanine into tyrosine in the GYP signature was 
carried out also in this construct, even though, no significant increase in 
hydrolytic activities was observed (fig.4.12).  
 
PDE activity in E.coli background 
Our data on purified PA4781 full-length and PA4781G are not in agreement 
with that previously reported by Ryan and co-workers (Ryan, et al., 2009), who 
demonstrated that P.aeruginosa mutant strains lacking PA4781 or PA4108 
genes presents lowered c-di-GMP intracellular levels. Moreover these authors 
demonstrated that PA4781 complements mutation into a X.campestris mutant 
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strain lacking the endogenous HD-GYP rpfG gene (strain characterized by high 
c-di-GMP levels). In order to understand the difference observed between the 
present study on purified proteins and previous in vivo results, we decided to 
analyze the effect of PA4108, PA4781 full-length and PA4781G 
overexpression on E.coli intracellular c-di-GMP levels. Overexpression of these 
proteins was verified by Western analysis with antisera against the His6 tag tail 
(not shown). 
The overexpression of these proteins was assayed using an E.coli strain mutant 
(AB1548), lacking the endogenous phosphodiesterase yhjH, which is 
characterized by higher levels of c-di-GMP. Intracellular content of c-di-GMP 
were determined by HPLC analysis and compared with those observed with 
the wild-type strain (MG1655) and with the AB1548 cells transformed with 
pet28b vector (as negative control).  
The overexperssion of PA4108 results in a significant reduction of c-di-GMP 
intracellular levels (fig. 4.13), thus restoring the levels observed in the wild-type 
strain (MG1655); this evidence indicates that cellular environment strongly 
enhanced the activity of this protein compared to the low hydrolytic activity 
measured in vitro on purified protein.  
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Figure 4.13. Effect of overexpression of PA4108, PA4781 or PA4781G on intracellular c-di-
GMP levels of a E.coli mutant strain, lacking the endogenous DGC YhjH. As control, the E.coli 
wild-type strain was also analysed. 
 
On the other hand, the overexpression of PA4781 protein did not alter c-di-
GMP content compared to the same strain transformed with the control 
vector (fig. 4.13). This result, in agreement with data on purified protein, 
indicated that the REC domain of PA4781 full length cannot be allosterically 
activated in the E. coli background. It is not excluded that a specific kinase 
targeting PA4781 REC domain is required and absent in E.coli. 
Surprisingly, a dramatic lowered c-di-GMP content was observed also in the 
strain transformed with PA4781G construct (fig. 4.13), which displays a 
nucleotides profile comparable to that found in the wild-type strain and in that 
expressing PA4108. This evidence indicates that, contrary to the full-length 
protein, the isolated catalytic domain of PA4781 is active in E. coli background. 
Moreover, also in the case of PA4781G, cellular environment strongly 
enhanced the PDE activity of the protein compared with that observed in the 
in vitro assay on purified protein.  
In order to gain mechanistic insights on PDE catalysis, the enzymatic activity of 
the aforementioned proteins was assayed also on soluble cell extract of wild-
type E.coli overexpressing strains. This experiment has been carried out also in 
a strain containing the sole pet28 vector as negative control. The assay was 
carried out through the addition of synthetic c-di-GMP to each cell extract and 
the consumption of this nucleotide was measured by reverse-phase 
chromatography, as previously described. According to the in vivo data 
described above, c-di-GMP hydrolysis was detected in the cell extract of the 
strain expressing PA4108 or PA4781G (fig. 4.14); these samples displayed c-di-
GMP levels comparable to the negative control, thus confirming the capability 
of E.coli milieu to strongly improve the catalytic activity of these proteins. On 
the other hand, lack of c-di-GMP consumption in the PA4781 full-length 
sample confirms the inability of the E. coli background to trigger the enzymatic 
activity of the full-length protein (fig. 4.14). 
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Figure 4.14. PDE activity on soluble cell extract of E.coli wild type strain transformed with 
PA4108, PA4781, or PA4781G. As contol, the wild-type strain containing the sole p28 vector 
was also analysed. 
 
The discrepancy between data in E.coli cells and those obtained with PA4108 
and PA4781G purified proteins may indicate that other species (possibly a 
partner or a cofactor lost during purification) assist these proteins during 
phosphodiesterase activity. This hypothesis is supported by literature data 
(Ryan, et al., 2010) on a HD-GYP protein (RpfG) from the plant pathogen 
Xanthomonas campestris pv. campestris (Xcc) that demonstrated the 
interaction between RpfG and a subset of GGDEF domain-containing protein. 
It has been shown that the physical interaction between RpfG and these 
GGDEF proteins influence some of the biological effects controlled by RpfG 
such as the regulation of motility (Ryan, et al., 2010).  
Interestingly, the control of motility by RpfG-GGDEF-protein complex does 
not depend to the PDE and/or DGC activity of both proteins; the role of this 
interaction seems to be to recruit a specific PilZ domain protein implicated in 
controlling motility in Xcc (Ryan, et al., 2012). It has been shown that protein-
protein interaction among proteins controlling the c-di-GMP levels, could play 
a key role in regulating different cellular functions in several bacteria (Abel, et 
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al., 2011; Duerig, et al., 2009; Newell, et al., 2011; Tschowri, et al., 2009). Our 
results suggest that also the HD-GYP proteins analysed in present study may 
need to interact with other cellular components to be active as PDE and to 
regulate different bacterial functions. 
 
4.2 New stategy for c-di-GMP detection and 
quantification 
As previously mentioned, the metabolic network involving c-di-GMP is highly 
complex and, despite the great effort in understanding the molecular basis of 
the c-di-GMP signalling pathways and the growing number of groups working 
on it, the exact molecular mechanism of c-di-GMP action remain to be fully 
elucidated. However, the dearth of detailed information regarding c-di-GMP 
signalling is probably due, also, to the lack of a rapid and unexpensive 
experimental strategy to readily detect c-di-GMP. In fact, despite several 
methods are available for c-di-GMP detection of, to date a strategy for in vitro 
detection and quantification of c-di-GMP is still not available for reliable real-
time measurements (tab 4.2).  
For this reason during my PhD, we developed a strategy that could provide 
significant advances and important clues to direct future experimental work on 
enzymes able to synthesize or degrade c-di-GMP (tab 4.2). 
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METHOD REAL-
TIME 
ADVANTAGE DISADVANTAGE ENZYME ANALYSED REF. 
    DGC  PDE(a)  
Circular  
Dichro ism*  
YES Pre-steady and steady-
state kinetics  
 
Micromolar detection limit 
 
PleD 
 
RocR 
PA4108 
1  
Thin Layer 
Chromatography 
(alfa32P-GTP or 
33P-C-DI-GMP) 
NO Good  
Sensitivity (<µM) 
Radiolabeled precursors 
required 
 
Enzyme inactivation step 
required prior analysis 
PleD  
DosC (b) 
All2874(b) 
 
 
 
 
 
CC3396 
PdeB  
(HD-GYP)  
2-8 
 
ENZ.CHECK 
Pyrophosphate 
Detect ion Kit®  
 
Coupled colorimetric 
assay (monitors  PPi 
production) 
YES Steady state kinetics Only valid for DGCs 
 
Upper limit for PPi detection 
(5 µM/min) 
 
Susceptible of Pi contamination 
WspR 
XCC4471 
PleD 
 9-11 
 
MALACHITE 
GREEN 
Coupled colorimetric 
assay (monitors  Pi 
production) 
NO  Enzyme inactivation step 
required prior analysis 
 
Susceptible of Pi contamination 
PleD(b)  12 
 
Reverse Phase-
HPLC 
 
Detection of nucleotides 
 
 
NO Nucleotides can be 
analysed by MS 
Enzyme inactivation step 
required prior analysis 
 
WspR(b) 
PleD 
PleD(b) 
HemDGC 
thermoDGC(b) 
 
 
 
 
 
 
 
RavR(b) 
RocR 
BlrP1 
PA2567 
PdeR 
RpfG  
(HD-GYP) 
2, 9,  
13-19 
 
DYE(S) 
BINDING 
to c-di-GMP 
quadruplex  
NO  Only valid for DGCs 
 
Limited Dye solubility 
 
Enzyme inactivation step 
required prior analysis 
 
Slow kinetics of complex 
formation 
WspR 
 
 
 20, 21 
Fluorescence 
(MANT-c-di-GMP) 
YES 
(PDEs) 
Steady state kinetics Only valid for PDEs 
 
 MSDGC-1 
 
22 
Tabel 4.2. Analytical methods used to measure enzymatic c-di-GMP synthesis and degradation 
Abbreviations: Pi: inorganic phosphate. PPi: inorganic pirophosphate. 
(a) All c-di-GMP phosphodiesterases listed in the Table belong to the EAL-type PDEs, unless specifically indicated in 
brackets.; (b) qualitative analysis:  catalytic parameters were not determined in the corresponding publication.; (c) due 
to lack of space the references are quoted as numbers in the table; the list of references is as below: 1) (Stelitano, et 
al.); 2) (Paul, et al., 2004); 3) (Christen, et al., 2006); 4) (Paul, et al., 2007); 5) (Tuckerman, et al., 2009); 6) (Neunuebel 
and Golden, 2008); 7) (Christen, et al., 2005); 8) (Sultan, et al., 2011); 9) (De, et al., 2008); 10) (Yang, et al., 2011); 11) 
(Wassmann, et al., 2007); 12) (Chan, et al., 2004); 13) (Lai, et al., 2009); 14) (Sawai, et al., 2010); 15) (Rao, et al., 2009); 
16) (He, et al., 2009) 17) (Rao, et al., 2008); 18) (Yang, et al., 2012); 19) (Ryan, et al., 2006); 20) (Nakayama, et al., 
2011)a; 21) (Nakayama, et al., 2011)b; 22) (Sharma, et al., 2012);  
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Formation of the complex between c-di-GMP and manganese  
The method presented here is based on the specific CD signal displayed by the 
intercalated dimer of c-di-GMP and on the ability of manganese ions to 
promote dimerization of this cyclic dinucleotide. The CD profile of c-di-GMP 
shows two peaks in the absence of metal ions, one positive at 255 nm and one 
negative at 282 nm, similarly to that of left-handed Z DNA and inverted 
relative to right handed DNA and RNA (fig 4.15) (Zhang, et al., 2006).  
 
Figure 4.15. Influence of divalent metal ions on c-di-GMP dimer formation analyzed in 50 mM 
Tris-HCl pH 7.5, 150 mM NaCl, at 10°C. MnCl2 and MgCl2 were added to a final 
concentration of 2.5 mM and 10 mM, respectively. 
 
A sigmoidal CD profile is obtained when two or more identical chromophores 
are in close proximity (Kelly and Price, 2000); in the case of c-di-GMP, which 
can form a stable dimer in solution, a strong hyperchromic effect is observed, 
as previously reported (Zhang, et al., 2006), due to the stacking of the four 
guanine rings. Since divalent metal ions are known to shift the equilibrium 
towards the dimer (Zhang, et al., 2004; Zhang, et al., 2006), we have analyzed 
the c-di-GMP CD profile in the presence of Mn2+ and/or Mg2+, which are 
normally added to the reaction buffer of DGCs and PDEs enzymatic assays. 
Surprisingly, while the influence of Mg2+ on the spectroscopic signal was not 
Chapter 4. Results and Discussion 
 
 47 
significative, we found that the intensity of both 255 nm and 282 nm peaks 
increases in the presence of Mn2+ (fig 4.15). This is due to the formation of a 
stable complex between the intercalated dimer of c-di-GMP and the 
manganese hydrated cation. Titration of c-di-GMP with Mn2+ shows that the 
CD signal at 282 nm reaches a plateau for Mn2+ concentrations above 2,5 mM 
(figure 4.16, inset) suggesting that the complex is more than 95% populated 
above this threshold.  
 
 
Figure 4.15. CD spectra of c-di-GMP showing the increase in the intensity of the dimer-specific 
peaks in the presence of increasing manganese concentrations, analyzed in 50 mM Tris-HCl pH 
7.5, 150 mM NaCl, at 10°C. (Inset) Plot of the CD signal at 282 nm as function of Mn2+ 
concentration. 95% of signal saturation is observed at 2.5 mM MnCl2 (i.e. KD for c-di-GMP-
Mn2+ complex formation of 262 ± 36 µM). The experimental data was fitted with a hyperbolic 
curve (continuous line). The signal is corrected for the Mn2+ free signal. 
 
The different dichroic features of c-di-GMP in the presence of Mn2+ and Mg2+ 
were unexpected due to the similarity of many properties between the two 
cations. Only two structures of a c-di-GMP intercalated dimer were solved, in 
complex with Mg2+ or Co2+ respectively, both in the early 90s (Egli, et al., 1990; 
Liaw, et al., 1990). Our group in collaboration with Prof.ssa Filomena Sica 
(Università di Napoli Federico II), has solved the crystal structure of c-di-GMP 
in complex with Mn2+ in order to establish whether this cation, compared to 
Mg2+ (Egli, et al., 1990), may induce any conformational changes in the 
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structural organization of the complex that could account for the different 
ability of the two divalent cations to populate the complex in solution. The 
crystal structure of the complex [Mn(H2O)4(c-di-GMP)2]
2+, determined at 0.9 
Å resolution, is shown in figure 4.16. 
 
Figure 4.16. Ball and stick representation of [Mn(H2O)4(c-di-GMP)2]
2+. Two c-di-GMP 
molecules are kept together by a manganese ion (cyan), which is six-coordinated by four water 
molecules (red) and the N7 and N7’ nitrogen atoms of guanines belonging to two different 
molecules. Each of the two axial water molecules is H-bonding to the carbonyl of one central 
guanine and to the oxygen of the cognate phosphate. The central base N1 of each molecule is 
hydrogen-bonded to the sugar phosphate backbone of the other. G-G base-pairing 
interactions stabilize both the dinucleotides and the overall assembly. Finally, The guanine rings 
coordinated to Mn2+ are forced out of the ideal coplanarity and appear partially unstacked 
similarly to the central bases of the complex with Mg2+ (Egli, et al., 1990). 
 
The structure shows non-significant differences with respect to that of the 
Mg2+-c-di-GMP complex (Egli, et al., 1990), indicating that the substitution of 
manganese with magnesium does not interfere with the assembly of the 
intercalated dimeric structure or with the binding mode of the metal ion. On 
the basis of these data it seems reasonable to assign the different effect of 
Mn2+ and Mg2+ on the dichroic spectra of c-di-GMP to the presence of d-
electrons in Mn2+, which contribute to the electrostatic interactions between 
the cation and guanine bases (Zhang and Huang, 2007) This is in agreement 
with the order of nucleotide-binding  ability of divalent cations (Mg2+< Co2+< 
Ni2+< Mn2+< Zn2+< Cd2+< Cu2+) deduced by empirical studies in the late 60’s 
(Eichhorn and Shin, 1968), and with quantum chemical calculations, which 
suggest that the different action of Mg2+ and Mn2+  toward nucleobases derives 
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from the greater polarization and charge-transfer effects in the Mn2+ complexes 
(Solt, et al., 2007; Sponer, et al., 2004) Finally, comparative studies of the 
guanine ligand binding properties of Mn2+, Zn2+, Ni2+ and Mg2+ have 
demonstrated that the transition metals shows an higher affinity for the 
nucleobase N7 . This could determine the stabilization of the complex in the 
presence of Mn2+ (Zhang and Huang, 2007). Accordingly, an enhancement of 
the CD signal similar to that of Mn2+ was observed also in the presence of zinc 
and nichel divalent cations (data not shown). 
The formation of the c-di-GMP-Mn2+ complex occurs rapidly, within five 
minutes at 10°C and within the mixing time at 25°C (data not shown). In the 
presence of 2.5 mM Mn2+, the CD signal shows a linear dependence on c-di-
GMP concentration; this linearity is maintained at the different temperatures 
analyzed (10, 25 and 37°C) (fig. 4.17).  
 
 
Figure 4.17. Linear dependence of the CD signal on c-di-GMP concentration. Analysis was 
performed at three different temperatures, i.e. 10, 25 and 37°C, in the following buffer: 20 mM 
Tris-HCl pH 8, 100 mM NaCl, 10 mM MgCl2, 1 mM BeCl2, 10 mM NaF and 2.5 mM MnCl2. 
The CD signals at 282 and 255 nm show the same profile. The assays were performed in 
duplicate. 
 
The CD signal of the samples is stable for at least 4 h in the temperature range 
needed for enzymatic reactions (10°C-37°C) and is also reproducible after a 
12 h storage at 4°C (not shown), making this method adaptable to very 
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different protocols; from real time detection to multiple analysis of many 
stored samples. The very intense CD signature of the intercalated dimer is 
specific, thus c-di-GMP can be detected and quantified (even in the low µM 
range) in the presence of all the other nucleotides involved in c-di-GMP 
turnover. GTP and GMP are spectroscopically silent in the near-UV region, 
while pGpG displays a CD spectrum with a single band at 255 nm that possibly 
originates from the coupling of the two guanines, which are in close proximity 
(fig. 4.18). However, since it does not significantly contribute at 282 nm, the 
presence of pGpG does not hamper the quantification of c-di-GMP at 282 nm 
(fig. 4.18).  
 
 
Figure 4.18. CD spectra of the nucleotides involved in c-di-GMP turnover. The nucleotides 
were analyzed at the concentration of 15 µM at 10°C in 50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 10 mM MgCl2 and 2.5 mM MnCl2. The spectrum of cyclic-di-AMP is also shown to 
compare the behaviour of the two cyclic dinucleotides (c-di-GMP and c-di-AMP). 
 
To assign the spectroscopic signature seen by CD to the stacking of the 
guanine bases, we have also measured the spectrum of another dinucleotide, 
i.e. 3’-5’ cyclic diadenilic acid (c-di-AMP): as shown in figure 4.18 this 
dinucleotide shows a much lower intensity and a different profile in the 
presence of Mn ions with respect to c-di-GMP. The observation that c-di-AMP 
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does not show the same spectroscopic signature of c-di-GMP strongly suggests 
that the sigmoidal CD signal arises from the stacking of the guanine bases. A 
comparison of the chemical structure of c-di-GMP and c-di-AMP highlights that 
the difference in the substituents in position N1 and the absence of the 
carbonyl group in the purine ring of c-di-AMP may disfavour the formation of a 
stacked dimer by c-di-AMP (fig. 4.19). 
 
. 
Figure 4.19. A) Position of N1, N7 and carbonyl in the purine ring of guanine compared to 
adenine. These atoms are involved both in dimer formation and in metal ion coordination, as 
illustrated in B), where they are highlighted in cyan, green and yellow respectively. N1 is 
involved in the formation of the c-di-GMP dimer serving as a donor in the H-bond between 
N1 and O2 of the cognate molecule. This H-bond cannot be formed by an hypothetical c-di-
AMP dimer since in adenine N1 is a hydrogen acceptor. N7 and the carbonyl are recruited for 
metal ion coordination, with N7 of the two central purines occupying two equatorial positions, 
while the carbonyl together with an oxygen of the cognate phosphate are H-bonding to the 
two water molecules in the axial position. In the purine ring of adenine, given that an amino 
group substitutes the carbonyl, this interaction cannot be established. 
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Probing the enzymatic activity of DGCs and PDEs in real-time  
The formation of the c-di-GMP/Mn2+ complex allows measuring c-di-GMP 
concentration in the working range typical of DGCs and PDEs enzymes. We 
have used the CD analysis to measure the enzymatic activity of two reference 
enzymes, i.e. PleD, a well characterized DGC from Caulobacter crescentus and 
RocR from Pseudomonas aeruginosa, an EAL-type PDE (Paul, et al., 2004; Rao, 
et al., 2008). 
The time course of the reactions catalysed by these two enzymes was 
measured in real-time at 282 nm as shown in Figure 6 (panels A and B, 
respectively). The reaction rates were found to be in good agreement with the 
published values (Paul, et al., 2007; Paul, et al., 2004; Rao, et al., 2008) (see 
Methods). As a control, the time course was also measured by extracting the 
nucleotides from aliquots of the reaction mixture taken at given times; these 
aliquots were then analyzed in parallel both by CD spectroscopy and by 
reverse phase HPLC chromatography, the most common method to quantify 
c-di-GMP (Antoniani, et al., 2009). The results obtained by CD analysis (point 
measurements) are fully consistent with data obtained by reverse phase HPLC. 
The comparison of the kinetics as followed by real-time measurements with 
that obtained by point measurements (see Figure 6) clearly shows (more 
evidently in the case of RocR) that the real-time approach is an absolute 
requirement for an accurate determination of the time course of the reaction.  
The time-course of the reaction of RocR was also measured in the absence of 
Mn2+ (with Mg2+ ions alone), and no difference was observed in the kinetic 
parameters (data not shown), suggesting that the real-time measurement can 
be carried out, if needed, also in the presence of Mg2+ ions alone (using a 
consistent calibration curve). 
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Figure 4.20. Time course of the reaction catalyzed by the diguanylate cyclase PleD (Panel A) 
and by the phosphodiesterase RocR (Panel B) as monitored in real-time by following the CD 
signal at 282 nm at 20°C (continuous line). As a control, the concentration of c-di-GMP in 
individual samples taken at given times during the reaction was determined separately by CD 
spectroscopy (black circles) and reverse-phase HPLC (black squares). All assays were 
performed in duplicate. The diguanylate cyclase activity of PleD (0.5 µM) was monitored using 
100 µM GTP (Panel A). The phosphodiesterase activity of RocR (0.5 µM) was monitored using 
30 µM c-di-GMP (Panel B). 
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The time course of the reactions catalysed by the HD-GYP protein PA4108 
was, also measured in real-time at 282 nm as shown in figure 4.21. Although, 
the CD signal at 282 nm is small due to the low activity of the protein, data 
obtained using the CD spectroscopy-based strategy, also in this case, are fully 
consistent with data obtained by reverse phase HPLC (point measurements) 
(fig. 4.21) 
 
Figure 4.21. Time course of the reaction catalyzed by the the phosphodiesterase HD-GYP 
PA4108 as monitored in real-time by following the CD signal at 282 nm at 30°C (continuous 
line). As a control, the concentration of c-di-GMP in individual samples taken at given times 
during the reaction was determined by reverse-phase HPLC (black circles). All assays were 
performed in duplicate. The phosphodiesterase activity of PA4108 (1,4 µM) was monitored 
using 30 µM c-di-GMP.  
 
Interestingly, we have also observed that, in the presence of the diguanylate 
cyclase PleD, the CD signal of c-di-GMP increases even in absence of 
manganese in the buffer (fig. 4.22, black circles). This is due to c-di-GMP 
binding to the enzyme inhibitory site as an intercalated dimer (Chan, et al., 
2004) with a similar structure of the c-di-GMP-Mn2+ complex (fig. 4.16).  
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Figure 4.22. Plot of the CD signal at 282 nm of samples containing increasing amounts of c-di-
GMP in presence of 10 µM PleD (monomer) (black circles) or 2.5 mM MnCl2 (red squares). 
Addition of 2.5 mM MnCl2 to the samples containing 25, 30, 35 and 40 µM c-di-GMP and 10 
µM PleD yields the same CD signal (blue triangles) of the manganese-alone samples. 
Experimental conditions: 20 mM Tris-HCl pH 8, 100 mM NaCl, 10 mM MgCl2, 1 mM BeCl2, 10 
mM NaF. The assays were performed in triplicate. 
 
Accordingly, titrating PleD with c-di-GMP the CD signal increases linearly with 
c-di-GMP concentration until all the inhibitory sites of PleD are saturated (i.e. a 
PleD:c-di-GMP binding stoichiometry of 1:2) (fig. 4.22). Further addition of c-di-
GMP does not correspond to a significant increase of the signal given that, in 
the absence of free binding sites, c-di-GMP is prevalently monomeric. Addition 
of manganese to the titration solution results in a further increase in the 
intensity of the signal, which indicates a shift of the equilibrium of free c-di-
GMP towards the dimeric form (fig. 4.22 blue triangles). This result confirms 
that a sigmoidal CD spectra peaking at 255 and 282 nm can be regarded as 
the spectroscopic fingerprint of the intercalated dimer. 
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CONCLUSIONS 
The involvement of the bacterial second messenger c-di-GMP in controlling 
biofilm formation and stimulation of the host immune system represents an hot 
topic among the scientific community due to the bioclinical relevance of 
biofilm-mediated infections. Despite the growing number of groups currently 
working on this attractive issue, few biochemical data are available on the 
enzymes involved in c-di-GMP homeostasis. This is particularly true for the 
HD-GYP subclass of phosphodiesterases, whose functional characterization is 
preliminary (Ryan, et al., 2010; Ryan, et al., 2012) and only one crystallographic 
structure (Lovering, et al., 2011) is available to date. 
The main aim of my PhD was thus to characterize this class of enzymes. This 
study has been carried out by analysing HD-GYP proteins from Pseudomonas 
aeruginosa, a model organism for studying biofilm. Particularly, two HD-GYP 
proteins, whose involvement in controlling biofilm has been demonstrated in 
vivo (Ryan, et al., 2009), have been analysed, namely PA4108 and PA4781. 
Surprisingly, in contrast to the results obtained by analysis of the role in 
P.aeruginosa biofilm formation (Ryan, et al., 2009), the functional 
characterization reported in this thesis indicates that purified PA4108 presents 
a very low c-di-GMP hydrolytic activity, while purified PA4781 results 
completely inactive. The latter enzyme contains a regulatory REC domain 
upstream of the catalytic one, which probably negatively regulates the enzyme 
when unphosphorylated. This regulatory mechanism has been indeed 
previously proposed for many other two-component regulators (Gao and 
Stock, 2010). The role of the REC domain in PA4781 was confirmed by the 
results on the isolated catalytic domain (PA4781G), which partially gains the c-
di-GMP hydrolytic activity, although with lower efficiency than PA4108.  
In order to better understand, on a structural basis, whether the observed lack 
of activity of PA4781 is due to the inability of the enzyme to bind c-di-GMP 
efficiently, the docking of c-di-GMP into the active sites of PA4108 and 
PA4781 was carried out in collaboration with Dr. A. Paiardini (Sapienza, 
Università di Roma). Briefly, once we obtained the homology models and the 
docking analysis of PA4108 and PA4781 (fig. 5.1A and 5.1B, respectively), using 
Bd1817 (pdb code: 3TM8) as a structural template, we identified the residues 
involved in the interaction of PA4108 with the substrate (fig 5.1C).  
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Figure 5.1. Molecular docking of c-di-GMP on PA4108 (A) and PA4781 (B) homology models 
obtained using as a structural template Bd1817; in panel C the interaction of PA4108 with the 
substrate is represented. 
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PA4108 is predicted to interact and accommodate c-di-GMP into a shallow 
binding groove, where a number of favourable interactions take place: the 
guanidine rings of c-di-GMP are stabilized by hydrogen-bonding interactions 
with Thr253, Arg298 and Asp201, and by arene-arene and arene-cation 
interactions with His221 and Lys196. The latter residue is also involved in an 
ion-pair interaction with a phosphate moiety of c-di-GMP. The other 
phosphate moiety is mainly stabilized by ion-pair interactions with Arg284. 
Interestingly, the latter residue is substituted by a His residue in PA4781 (fig. 
5.1B). This substitution could be responsible, at least in part, of the observed 
low affinity of PA4781 for c-di-GMP. This feature, together with the negative 
effect of the REC domain discussed above, may explain the observed inability 
of PA4781 to hydrolyze c-di-GMP in vitro. 
It should be underlined that also PA4108 displays a very low catalytic activity 
and high KM for c-di-GMP (compared to the known EAL PDE (Rao, et al., 
2009; Rao, et al., 2008)). The unexpected evidence of the very low activity of 
the aforementioned HD-GYP proteins in vitro and the literature data available 
on the family archetype RpfG (Ryan, et al., 2010; Ryan, et al., 2012) suggest that 
the HD-GYP proteins might act as enzymes or signals, depending on the 
cellular context. This hypothesis is in agreement with recent data showing that 
proteins involved in c-di-GMP signalling can be multifunctional, with other 
activities assisting or replacing the predicted enzymatic function (as an example 
see (Ryan, et al., 2012)).  
Contrary to the data on purified proteins, the assays performed in the E.coli 
background presented in this thesis demonstrate that the expression of 
PA4108 and PA4781G (containing only the catalytic domain of PA4781) 
influence significantly the intracellular levels of c-di-GMP. For this reason, we 
propose that, in the cell, other partners or cofactors are required to trigger the 
PDE activity of PA4108 and PA4781G. We expect to extend this analysis by 
solving the structure of PA4781G, whose crystals have been obtained very 
recently. 
Anyhow, the E.coli milieu does not revert the negative regulatory effect of the 
REC domain on the full-length PA4781, suggesting that this protein needs a 
specific kinase (absent in E.coli) for its phosphorylation. 
Experiments aimed at identifying the putative partners of PA4108 and PA4781 
are currently ongoing by means of a pull-down approach on both E.coli and, 
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more interestingly, P.aeruginosa cell extracts. Moreover, we plan to identify a 
third actor of this metabolic pathway, i.e. the specific kinase able to 
phosphorylate in P.aeruginosa the PA4781 REC domain, by merging 
bioinformatics, microbiology and biochemistry.  
The present and future studies on the biochemistry of c-di-GMP synthesis and 
consumption are strongly limited by the detection methods currently available 
to detect c-di-GMP. For this reason, during my PhD I have developed a new 
strategy for the detection and identification of c-di-GMP. This method is based 
on the specific CD signal displayed by the intercalated dimer of c-di-GMP and 
on the ability of manganese ions to promote dimerization of this cyclic 
dinucleotide. This approach can be employed to measure the enzymatic rate of 
c-di-GMP production and degradation, as shown by the real-time 
measurements presented above. The CD signal of c-di-GMP at 282 nm is very 
specific of the dimeric form of the molecule; other nucleotides such as GTP, 
pGpG or GMP, which are present during the reaction of diguanylate cyclases 
or phosphodiesterases, do not show the same signal. Moreover, the 
observation that the adenine dinucleotide c-di-AMP does not have the same 
spectroscopic signature suggests that the sigmoidal CD signal can be assigned 
to the stacking of the guanine bases.  
Comparison of the distinctive features of present strategy with those of the 
other strategies available to measure enzymatic activities (as summarized in tab. 
4.I) underlines that this method is effective to measure steady-state kinetics of 
both DGCs and PDEs in real-time. As shown in table 4.I, the kinetic properties 
of few enzymes have been studied to date with the methods already available; 
on the other hand, it is clear that a deep understanding of the mechanism 
controlling the turnover of c-di-GMP requires the biochemistry of its synthesis 
and degradation to be fully elucidated. A clear advantage of the approach 
presented here is that it allows to detect and quantify c-di-GMP directly, 
without the need of additional chromophores, biosensors or dyes, and does 
not require time-consuming sample preparation. In common with most 
methods, the sensitivity of the CD analysis lies in the micromolar range of c-di-
GMP concentrations (tab. 4.I).  
In our opinion the present experimental approach also opens novel scenarios 
and attractive possibilities in the field of c-di-GMP enzymes. The method will 
allow to conceive pre-steady kinetic experiments, to date unexplored for these 
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enzymes, but of crucial value to determine the reaction mechanism of both 
DGCs and PDEs. A detailed knowledge of the mechanistic details of these 
reactions is a necessary pre-requisite to design and to validate effective 
inhibitors that could be used as antimicrobial agents able to modulate c-di-
GMP levels and to interfere with the formation of biofilms or with 
development of specific (antibiotic-resistant) phenotypes such as those found 
in persister cells (Malone, et al., 2012).  Moreover, the experimental approach 
presented here might be employed to explore the interplay of DGCs and 
PDEs in controlling c-di-GMP levels by allowing to measure the activity of 
these enzymes not only individually, but also in combination in the same 
reaction mixture; this may provide quantitative evaluation of the interaction of 
proteins putatively involved in the same signalling pathway. As suggested by the 
recent evaluation of the different phenotypic output of the activity of the 
DCGs in Vibrio cholerae, the mechanism and rate whereby each individual DCG 
produces c-di-GMP and/or is regulated determine the stringent biological 
specificity of c-di-GMP signalling in the cell (Massie, et al., 2012). 
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